Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Detalles Bibliográficos
Autores principales: Edmonds, Sterling, MacGregor, Andrea, Doll, Agnieszka, Vural, Ipek Eren, Graham, Janice, Fierlbeck, Katherine, Lexchin, Joel, Doshi, Peter, Herder, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717257/
https://www.ncbi.nlm.nih.gov/pubmed/33537149
http://dx.doi.org/10.1093/jlb/lsaa083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717257/
https://www.ncbi.nlm.nih.gov/pubmed/33537149
http://dx.doi.org/10.1093/jlb/lsaa083

Ejemplares similares